The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Glycosylated Peptide Market Research Report 2024

Global Glycosylated Peptide Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1415819

No of Pages : 91

Synopsis

The global Glycosylated Peptide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Glycosylated Peptide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Glycosylated Peptide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Glycosylated Peptide include Sandoz International, Pfizer, Roche, Teva Pharmaceuticals Industries, Celltrion, Biocon, Dr.Reddys Laboratories, Medtronic and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Glycosylated Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycosylated Peptide.

Report Scope

The Glycosylated Peptide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycosylated Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glycosylated Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Sandoz International
  • Pfizer
  • Roche
  • Teva Pharmaceuticals Industries
  • Celltrion
  • Biocon
  • Dr.Reddys Laboratories
  • Medtronic
  • Cipla
  • Bachem Americas

Segment by Type

  • Monoclonal Antibodies (MABs)
  • Erythropoietin (EPO)
  • Others

Segment by Application

  • Oncology
  • Blood Disorder
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycosylated Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycosylated Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Glycosylated Peptide Market Overview
1.1 Product Overview and Scope of Glycosylated Peptide
1.2 Glycosylated Peptide Segment by Type
1.2.1 Global Glycosylated Peptide Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Erythropoietin (EPO)
1.2.4 Others
1.3 Glycosylated Peptide Segment by Application
1.3.1 Global Glycosylated Peptide Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Blood Disorder
1.3.4 Others
1.4 Global Glycosylated Peptide Market Size Estimates and Forecasts
1.4.1 Global Glycosylated Peptide Revenue 2019-2030
1.4.2 Global Glycosylated Peptide Sales 2019-2030
1.4.3 Global Glycosylated Peptide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glycosylated Peptide Market Competition by Manufacturers
2.1 Global Glycosylated Peptide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glycosylated Peptide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glycosylated Peptide Average Price by Manufacturers (2019-2024)
2.4 Global Glycosylated Peptide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glycosylated Peptide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycosylated Peptide, Product Type & Application
2.7 Glycosylated Peptide Market Competitive Situation and Trends
2.7.1 Glycosylated Peptide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycosylated Peptide Players Market Share by Revenue
2.7.3 Global Glycosylated Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycosylated Peptide Retrospective Market Scenario by Region
3.1 Global Glycosylated Peptide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glycosylated Peptide Global Glycosylated Peptide Sales by Region: 2019-2030
3.2.1 Global Glycosylated Peptide Sales by Region: 2019-2024
3.2.2 Global Glycosylated Peptide Sales by Region: 2025-2030
3.3 Global Glycosylated Peptide Global Glycosylated Peptide Revenue by Region: 2019-2030
3.3.1 Global Glycosylated Peptide Revenue by Region: 2019-2024
3.3.2 Global Glycosylated Peptide Revenue by Region: 2025-2030
3.4 North America Glycosylated Peptide Market Facts & Figures by Country
3.4.1 North America Glycosylated Peptide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glycosylated Peptide Sales by Country (2019-2030)
3.4.3 North America Glycosylated Peptide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycosylated Peptide Market Facts & Figures by Country
3.5.1 Europe Glycosylated Peptide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glycosylated Peptide Sales by Country (2019-2030)
3.5.3 Europe Glycosylated Peptide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycosylated Peptide Market Facts & Figures by Country
3.6.1 Asia Pacific Glycosylated Peptide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glycosylated Peptide Sales by Country (2019-2030)
3.6.3 Asia Pacific Glycosylated Peptide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycosylated Peptide Market Facts & Figures by Country
3.7.1 Latin America Glycosylated Peptide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glycosylated Peptide Sales by Country (2019-2030)
3.7.3 Latin America Glycosylated Peptide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycosylated Peptide Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycosylated Peptide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glycosylated Peptide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glycosylated Peptide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glycosylated Peptide Sales by Type (2019-2030)
4.1.1 Global Glycosylated Peptide Sales by Type (2019-2024)
4.1.2 Global Glycosylated Peptide Sales by Type (2025-2030)
4.1.3 Global Glycosylated Peptide Sales Market Share by Type (2019-2030)
4.2 Global Glycosylated Peptide Revenue by Type (2019-2030)
4.2.1 Global Glycosylated Peptide Revenue by Type (2019-2024)
4.2.2 Global Glycosylated Peptide Revenue by Type (2025-2030)
4.2.3 Global Glycosylated Peptide Revenue Market Share by Type (2019-2030)
4.3 Global Glycosylated Peptide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glycosylated Peptide Sales by Application (2019-2030)
5.1.1 Global Glycosylated Peptide Sales by Application (2019-2024)
5.1.2 Global Glycosylated Peptide Sales by Application (2025-2030)
5.1.3 Global Glycosylated Peptide Sales Market Share by Application (2019-2030)
5.2 Global Glycosylated Peptide Revenue by Application (2019-2030)
5.2.1 Global Glycosylated Peptide Revenue by Application (2019-2024)
5.2.2 Global Glycosylated Peptide Revenue by Application (2025-2030)
5.2.3 Global Glycosylated Peptide Revenue Market Share by Application (2019-2030)
5.3 Global Glycosylated Peptide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sandoz International
6.1.1 Sandoz International Corporation Information
6.1.2 Sandoz International Description and Business Overview
6.1.3 Sandoz International Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sandoz International Glycosylated Peptide Product Portfolio
6.1.5 Sandoz International Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Glycosylated Peptide Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Glycosylated Peptide Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Teva Pharmaceuticals Industries
6.4.1 Teva Pharmaceuticals Industries Corporation Information
6.4.2 Teva Pharmaceuticals Industries Description and Business Overview
6.4.3 Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Industries Glycosylated Peptide Product Portfolio
6.4.5 Teva Pharmaceuticals Industries Recent Developments/Updates
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Description and Business Overview
6.5.3 Celltrion Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Celltrion Glycosylated Peptide Product Portfolio
6.5.5 Celltrion Recent Developments/Updates
6.6 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocon Glycosylated Peptide Product Portfolio
6.6.5 Biocon Recent Developments/Updates
6.7 Dr.Reddys Laboratories
6.6.1 Dr.Reddys Laboratories Corporation Information
6.6.2 Dr.Reddys Laboratories Description and Business Overview
6.6.3 Dr.Reddys Laboratories Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr.Reddys Laboratories Glycosylated Peptide Product Portfolio
6.7.5 Dr.Reddys Laboratories Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Corporation Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtronic Glycosylated Peptide Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Glycosylated Peptide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Bachem Americas
6.10.1 Bachem Americas Corporation Information
6.10.2 Bachem Americas Description and Business Overview
6.10.3 Bachem Americas Glycosylated Peptide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bachem Americas Glycosylated Peptide Product Portfolio
6.10.5 Bachem Americas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycosylated Peptide Industry Chain Analysis
7.2 Glycosylated Peptide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycosylated Peptide Production Mode & Process
7.4 Glycosylated Peptide Sales and Marketing
7.4.1 Glycosylated Peptide Sales Channels
7.4.2 Glycosylated Peptide Distributors
7.5 Glycosylated Peptide Customers
8 Glycosylated Peptide Market Dynamics
8.1 Glycosylated Peptide Industry Trends
8.2 Glycosylated Peptide Market Drivers
8.3 Glycosylated Peptide Market Challenges
8.4 Glycosylated Peptide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’